Release Date: 01/11/19 14:08 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 2.01MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%